Ricin is a potent A-B toxin that is transported from the cell surface to the cytosol where it inactivates ribosomes leading to cell death. Ricin enters cells via endocytosis where only a minute number of ricin molecules reach the ER 1 (endoplasmic reticulum) lumen. Subsequently, the ricin A chain traverses the ER bilayer by a process referred to as dislocation or retrograde translocation to gain access to the cytosol. In order to study the molecular processes of ricin A chain dislocation, we have established for the first time a human cell system in which enzymatically attenuated ricin A chains (RTA E177D and RTA Δ ) are expressed in the cell and directed to the ER. Using this human cell based system, ricin A chains were found to undergo a rapid dislocation event that was quite distinct than the dislocation of a canonical ER soluble misfolded protein, α 1 -antitrypsin HKnull . Remarkably, ricin A chain dislocation occurred via a membrane integrated intermediate and utilized the ER protein SEL1L (suppressor of lin-12-like) for transport across the ER bilayer to inhibit protein synthesis. The data support a model that ricin A chain dislocation occurs via a novel strategy of utilizing the hydrophobic nature of the ER membrane and selective ER components to gain access to the cytosol.
Ricin is a potent A-B toxin that is transported from the cell surface to the cytosol where it inactivates ribosomes leading to cell death. Ricin enters cells via endocytosis where only a minute number of ricin molecules reach the ER 1 (endoplasmic reticulum) lumen. Subsequently, the ricin A chain traverses the ER bilayer by a process referred to as dislocation or retrograde translocation to gain access to the cytosol. In order to study the molecular processes of ricin A chain dislocation, we have established for the first time a human cell system in which enzymatically attenuated ricin A chains (RTA E177D and RTA Δ ) are expressed in the cell and directed to the ER. Using this human cell based system, ricin A chains were found to undergo a rapid dislocation event that was quite distinct than the dislocation of a canonical ER soluble misfolded protein, α 1 -antitrypsin HKnull . Remarkably, ricin A chain dislocation occurred via a membrane integrated intermediate and utilized the ER protein SEL1L (suppressor of lin-12-like) for transport across the ER bilayer to inhibit protein synthesis. The data support a model that ricin A chain dislocation occurs via a novel strategy of utilizing the hydrophobic nature of the ER membrane and selective ER components to gain access to the cytosol.
Ricin toxin is a toxic polypeptide found in castor beans (Ricinis communis) (1) comprised of a catalytically active polypeptide (A chain or RTA) covalently linked by a disulfide bond to a lectin binding B subunit (RTB). Like most A-B toxins, the specificity of the B chains for cell surface receptors dictates cell entry. In the case for ricin toxin, the galactose-specific lectin binding domain of the B chain interacts with cell surface glycolipids and glycoproteins allowing the toxin to enter the cell via clathrin-dependent and clathrin-independent endocytosis (2) .
Following endocytosis, ricin toxin is transported in a retrograde manner through the Golgi, ER and into the cytosol by a similar manner as shiga toxin, cholera toxin, Pseudomonas exotoxin A, and pertussis toxin (3) . These toxins are proposed to utilize protein kinases during the endocytosis step (4) . In contrast, other AB toxins such as diphtheria toxin and anthrax toxin enter the cytoplasm following a low pH induced translocation event directly from endocytic vesicles (3) .
The retrograde trafficking of ERdirected toxins requires numerous cellular factors to reach the ER lumen (4) . Both ricin and Shiga toxin are dependent on Vps34, a PI3 kinase, and members of the sorting nexins family of proteins. In the case of ricin toxin, it is independent of Rab-9 and -11 (5) and dependent on dynamin (6) and cellular cholesterol levels (7) . A recent highthroughput screen identified small molecule inhibitors that demonstrate the ability to protect cells from ricin toxicity by targeting endosome-to-Golgi retrieval factors, specifically syntaxin 5 and 6 (8) .
Despite the lack of a KDEL sequence, the heterodimer is transported from the Golgi apparatus to the ER lumen. While in the ER, the ricin A chain disassociates from RTB and is transported across the membrane by a process referred to as dislocation or retrograde translocation (9) . Once in the cytosol, the A chain acts as an N-glycosidase which inactivates the ribosome and eventually causing cell death. However, ricin-induced cell death may also be due to inhibition of processes other than translation shut-down (10) .
Ricin is a member of the A-B family of toxins (e.g. shiga, cholera, Pseudomonas exotoxin A, or pertussis toxin) that reach the ER lumen and are ultimately transported into the cytosol (3). Ricin takes advantage of the ER quality control machinery -a cellular system that normally scrutinizes nascent polypeptides and disposes of misfolded proteins by proteasome destruction (11) . The ER chaperones PDI and calreticulin are proposed to play a role in ricin transport across the ER membrane (12, 13) . In addition, the ER degradation enhancing α-mannosidase I-like protein involved in degradation of misfolded ER proteins (14) also participates in ricin dislocation (15) . Recently, ricin studies in yeast cells found that Hrd1p was implicated in ricin dislocation (16) . The toxin is proposed to be extracted through the ER membrane via the Sec61 translocon (17) , but a recent study suggests that the Hrd1p complex may act as the dislocon (18) . Once dislocated, the Hsc70 cytosolic chaperone machinery protects ricin A chain from Hsp90 assisted cytosolic degradation (19) . The mechanism of ricin dislocation in human cells has not been well defined despite the identification of cellular factors that ricin utilizes for dislocation.
The potency of ricin to inactivate 2,000 ribosomes/minute precludes the need for a large number of molecules to reach the cytoplasm (20, 21) . In order to characterize one of the rate limiting steps of ricin entry, dislocation, a human cell system has been created for the first time that expresses an enzymatic mutant of ricin A chain in the ER. Using this model system, ricin A chain dislocation occurs in a unique manner utilizing the ER membrane itself as well as ER proteins. Human U373-MG  astrocytoma expressing RTA polypeptides  (U373 RTAΔ and U373 RTA-E177D ) were generated and maintained as described (22) . Anti-ricin toxin, anti-GAPDH, anti-α 1 antitrypsin, anti-SEL1L, anti-gamma tubulin, anti-GFP and anti-p97 antibodies were purchased from Biodesign International, Millipore Corporation, Chemicon International Inc., Sigma, Santa Cruz, and AbCam, respectively. Anti-HA (12CA5) antibodies were purified from hybridoma cells (23) . The anti-calnexin monoclonal antibody (AF8) (Hochstenbach, et al., 1992) and anti-PDI antibody were gifts from Dr. Brenner (Harvard Medical School, Boston, MA) and Dr. Ploegh (Whitehead Institute, Cambridge, MA), respectively.
EXPERIMENTAL PROCEDURES

Cell lines and antibodies:
cDNA constructs: Ricin toxin mutant chimeras RTA E177D and RTA Δ177-181 (RTA Δ ) (24) were generated from PCR fragments (22) using full length wild type ricin toxin A chain (FL-RTA WT ) cDNA as a template. The RTA E177D represents a site-directed point mutant in which residue 177 (glutamic acid, E) was changed to aspartic acid (D). The RTA Δ mutant is a deletion construct lacking residues 177-EAARF-181. Finally, the chimeras consisted of an amino terminal murine MHC class I heavy chain H2-K b signal peptide (K b ) followed by the hemagglutinin (HA) epitope tag (AYPYDVPDYA), linker region (15 aa) and RTA WT , RTA E177D or RTA Δ . The Derlin-1-GFP construct was generated as a chimera by fusing the Derlin-1 cDNA to EGFP cDNA. The shRNA construct against SEL1L was a kind gift from Dr. Ploegh (Whitehead Institute). SEL1L knockdown in HeLa cells was performed using shRNAs from Santa Cruz Biotech.
Cell lysis, Immunoprecipitation, SDS-PAGE, Endoglycosidase H and peptide N-glycanase assays: Briefly, cells (1 X 10 6 ) were lysed in 0.5% Nonident P (NP)-40 lysis mix followed by incubation with the respective antibody and protein A agarose beads (22) . The immunoprecipitates were subjected to immunoblot analysis using the respective immunoglobulin. Endoglycosidase H and peptide N-glycanase (New England Biolabs) assays were performed at 37 o C for 1.5 hrs (100 units enzyme/reaction).
Pulse-chase analysis: Briefly, cells were labeled with 35 S-methionine and chased in cold methionine (25 mM) (22) . RTA proteins were recovered from NP-40 cell lysates using anti-HA antibodies and resolved using SDS-PAGE (12.5%). The polyacrylamide gels were dried and exposed to autoradiography film. The polypeptide levels were quantified by densitometry analysis using an Alpha Imager 3400 (Alpha Innotech).
Subcellular fractionation: RTA expressing cells were mechanically homogenized using a 12 mm ball bearing homogenizer (12 passes) (Isobiotec, Heidelberg, Germany) in homogenization buffer (100 mM Tris, 150 mM NaCl, 250 mM sucrose, 1.5 µg/ml aprotinin, 1 µM leupeptin, and 200 mM phenylmethylsulfonyl fluoride) (25) . Unbroken cells and other debris were pelleted at 15,000g (10 min @ 4 o C) and the supernatants were untreated or treated with 4.5M urea (final) (10 min @ 4 o C). Supernatants were centrifuged at 100,000g (1 h @ 4 o C). 100,000g supernatants and pellets were resolved by SDS-PAGE (12.5%).
Isoelectric focusing:
The RTA precipitates were incubated with isoelectric focusing sample buffer (57% (w/v) urea, 2% (v/v) NP-40, 0.02% ampholytes pH 3.5-10 (Amersham Biosciences), 0.025% 2-mercaptoethanol), and resolved on a 17-cm 1D-IEF gel (57% (w/v) urea, 2% (v/v) NP-40, 15.5% acrylamide (30/1.6 acrylamide/bisacrylamide), 4% ampholytes pH 5-7, 1% ampholytes pH 3.5-10, 0.4% ampholytes pH 7-9) for 14 hrs. After electrophoresis, the gel was soaked in 50% methanol, 1% (w/v) SDS, 5 mM Tris Cl, pH 8.0 for 2 hrs and subjected to immunoblot analysis (25) . 
RESULTS
Ricin A chains directed to the ER block protein synthesis.
The investigation of ricin toxin transport across the ER membrane has been hampered by the low number of toxin molecules that reach the ER lumen when added extracellularly (17) . Hence, we aimed to create a human cell-based assay to specifically study RTA transport across the ER membrane. In line with this objective, we initially confirmed that RTA molecules directed to the ER (10, 26) Figure 1B , 85%). These data suggest that ER directed RTA molecules are dislocated across the ER and to the cytosol where they inhibit protein synthesis.
Ricin A chain expression in human cells
Due to the toxic nature of wild type RTA, we cloned ricin A chain mutants (RTA E177D and RTA Δ , Experimental by guest on September 1, 2017
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Procedures) that are enzymatically attenuated to study A chain dislocation (27, 28) . RTA E177D is a site-directed mutant with attenuated activity that is structurally similar to wild type (29) , while RTA Δ has deletion of residues 177-181. These constructs like RTA WT were also engineered with the N-terminal K b signal peptide and HA epitope tag. An initial experiment was performed to determine whether RTA E177D and RTA Δ inhibit protein synthesis. GFP positive cells were examined in HEK-293T cells co-transfected with RTA E177D and RTA Δ and a GFP expression plasmid ( Figure 1E-F) . The RTA mutants, RTA E177D and RTA Δ had a diminished ability to affect GFP expression (Figure 1E-F) with RTA E177D retaining some capacity to inhibit GFP expression. These data demonstrate that ricin A chain mutants have limited capacity to prevent protein expression.
In order to study RTA dislocation, human U373 cells that stably express RTA E177D and RTA Δ (Experimental Procedures) ( Figure 2 ) were created. Our initial experiment examined the acquisition of an N-linked glycan onto RTA E177D and RTA Δ to confirm their localization to the ER. RTA E177D and RTA Δ molecules recovered from these cells were subjected to Endo H treatment followed by immunoblot analysis (Figure 2A ). Endo H preferentially cleaves immature high mannose containing N-linked oligosaccharides characteristic of ER-resident molecules (30) . RTA E177D and RTA Δ polypeptides with the predicted molecular weight were recovered from cell lysates ( Figure 2A , lanes 3 and 5). As expected, faster migrating RTA polypeptides were observed upon treatment with Endo H (Figure 2A, lanes 2, 4, and 6) . The difference in the relative molecular weight of the two species (~3-4 kDa) confirmed that the RTA polypeptides acquired a single N-linked glycan and were retained in the ER. These data demonstrate that this human cell-based assay can be utilized to study ricin dislocation.
Ricin A chains are subjected to proteasome degradation.
We next investigated the stability of the RTA polypeptides in U373 RTA-E177D and U373 RTAΔ cells by pulse-chase analysis ( Figure  2B and C). The cells were metabolically labeled with 35 S-methionine for 15 min and chased up to 60 min. Strikingly, the half-life of RTA E177D (<10 min) was less than RTA Δ (~ 20 min) ( Figure 2B, lanes 1-8 and 2C ). Given that ricin utilizes ER quality control to gain access to the cytosol (9, 16) , it is expected that a population of ricin would be degraded. However, the rapid half-life of RTA E177D expressed in human cells when compared to yeast (16, 26) and plant cells (31, 32) suggests that RTA is efficiently transported out of the ER in human cells.
Are RTA polypeptides targeted for proteasome dependent degradation? To address this question, U373 RTA-E177D and U373 RTAΔ cells treated with or without proteasome inhibitor carboxybenzyl-leucylleucyl-leucyl vinyl sulfone (ZL 3 VS) (25 µM, 1 hr) were subjected to pulse-chase analysis ( Figure 3 ). As expected, RTA polypeptides decreased over the chase period ( Figure 3A and B, lanes 1-3). Strikingly, the inclusion of proteasome inhibitor stabilized both RTA E177D and RTA Δ molecules ( Figure 3A and B, lanes 4-6). In addition, proteasome inhibition enabled the recovery of a faster migrating polypeptide intermediate (*) during the chase, most likely deglycosylated RTA species ( Figure 3A and B, *, lanes 4-6). Collectively, the data demonstrate that ricin A chains are eventually degraded in a proteasome dependent manner.
Characterization of RTA E177D and RTA Δ intermediates.
We next optimized conditions to observe the faster migrating RTA species. Total cell lysates from U373 RTA-E177D and U373 RTAΔ cells treated with proteasome inhibitor ZL 3 VS (10 µM) for up to 5 hours were subjected to immunoblot analysis ( Figure  4A ). Strikingly, RTA E177D proteins were almost completely converted to the faster migrating species after 2 hrs of ZL 3 VS treatment ( Figure 4A, lanes 9-12) . In contrast, RTA Δ molecules displayed a biphasic conversion in which an increase in glycosylated RTA Δ was observed during the early times of proteasome inhibition ( Figure  4A , lanes 2-3) followed by an accumulation of glycosylated and faster migrating species during later times of ZL 3 VS treatment ( Figure  4A, lanes 4-6) . Interesting, the ratio of glycosylated (RTA(+)CHO) to faster migrating species following proteasome treatment significantly varied between the RTA mutants ( Figure 4A , lanes 1-6 and 7-12, respectively). These results suggest that RTA E177D and RTA Δ are likely processed differently due to the folding status of the polypeptide.
To address the N-linked glycosylation status of the RTA Δ and RTA E177D intermediates, we examined their sensitivity to in vitro glycosidase treatment ( Figure 4B ). RTA polypeptides recovered from U373 RTA-
E177D
and U373 RTAΔ cells treated with proteasome inhibitor (2.5 µM, 10 hours) were undigested or digested with EndoH (EH) or peptide N-glycanase (PNGase or PN) followed by immunoblot analysis ( Figure 4B ). U373 cells were used as a negative control. As expected, two species of RTA polypeptides were observed exclusively from proteasomeinhibitor treated cells ( Figure 4B, lanes 10 and  16) . Moreover, only the slower migrating glycosylated species were sensitive to EndoH and PNGase digestion resulting in the faster migrating form of the RTA-reactive polypeptides ( Figure 4B, lanes 11-12 and 17-18 ). Calnexin levels demonstrated equivalent protein loading ( Figure 4B, lanes 19-36) . These data suggest that the faster migrating RTA species are deglycosylated intermediates generated from the dislocation of ricin polypeptides.
In order to confirm that the N-terminal epitope tag does not affect the processing of the RTA polypeptides, we examined the accumulation of untagged RTA mutants upon proteasome inhibition (Supplemental Figure  1) . Cell lysates from proteasome inhibitor treated U373, U373 RTA-E177D , U373 KbRTA∆ , and U373 KbRTA-E177D cells were subjected to immunoblot analysis. Two species of RTA molecules, glycosylated and deglycosylated, accumulated in proteasome inhibitor treated cells; a result demonstrating that the stability of both forms of RTA is independent of the Nterminus epitope tag.
To confirm that the faster migrating RTA species were indeed digested by cellular PNGase, the RTA polypeptides were resolved on a 1D-IEF gel. PNGase cleavage results in the conversion of asparagine to aspartic acid causing a more acidic species, thus changing the overall charge of the polypeptide (33) . RTA polypeptides recovered from U373 RTA-E177D cells treated with proteasome inhibitor (2.5 µM, 10 hours) were untreated or treated with EndoH or PNGase, resolved on a 1D-IEF gel and subjected to immunoblot analysis ( Figure 4C ). RTA E177D polypeptides from ZL 3 VS-treated cells migrated as two discrete bands likely corresponding to species with different charges ( Figure 4C , lane 1, (* and **)). Strikingly, in vitro PNGase digestion of RTA E177D polypeptides caused the polypeptides to migrate at a similar position as the more acidic RTA molecules ( Figure 4C , lane 2, **), while EndoH treatment did not alter the migration pattern of the RTA E177D polypeptides ( Figure 4C, lane 3) . The same result was observed for RTA Δ 2 . These results demonstrate that RTA polypeptides are subjected to cellular deglycosylation during dislocation.
Ricin A chains utilize ER membrane factors for efficient dislocation.
To characterize the membrane topology of stabilized RTA polypeptides, we performed a subcellular fractionation protocol (Experimental Procedures). Membrane microsomes from U373 RTA-E177D and U373 RTAΔ cells treated with proteasome inhibitor (2.5 mM, 10 hrs) were incubated with 4.5M urea and subjected to high-speed centrifugation (100,000g) to separate the membrane fraction from the supernatant fraction. The 100,000g supernatant, 100,000g pellet, and total cell lysates were subjected to immunoblot analysis for RTA mutants ( Figure 5 , lanes 1-10) and p97 ( Figure 5, lanes 11-20) . The p97 polypeptide is a soluble cytosolic protein that associates with the ER membrane (34) and as expected, was completely extracted from the bilayer upon treatment with urea ( Figure 5,  lanes 12 and 14) . As expected, some of the stabilized RTA E177D and RTA Δ molecules were found in the 100,000g supernatant ( Figure 5 , lanes 6 and 8), Strikingly, a significant population of RTA E177D and RTA Δ was observed with the membrane fraction ( Figure  5 , lanes 2 and 4) demonstrating that these RTA molecules are integrated into the bilayer. These results imply that ricin A chains are efficiently dislocated via membrane-integrated intermediates.
Ricin A chains are dislocated utilizing selective components of ER quality control.
To validate that RTA polypeptides were dislocated utilizing the ER quality control machinery, we examined the effect of a dislocation inhibitor, eeyarestatin I (35), on the stability of ricin A chains. U373 RTA-E177D and U373 RTAΔ cells treated with or without eeyarestatin (5µg/mL) or the proteasome inhibitor ZL 3 VS (2.5 µM) were subjected to immunoblot analysis ( Figure 6A ). PDI levels assured equivalent protein loading ( Figure 6A , lanes 9-16). As expected, treatment with ZL 3 VS caused a significant increase in both RTA Δ and RTA E177D polypeptides ( Figure 6A , lanes 5-8) with a difference between the levels of glycosylated (RTA(+)CHO) and deglycosylated (RTA(-)CHO) molecules. Interestingly, mostly glycosylated RTA Δ and RTA E177D polypeptides accumulated from cells treated with eeyarestatin I ( Figure 6A , lanes 2 and 4). However, since eeyarestatin I attenuates the process of dislocation and not proteasome function (35) , it was interesting that deglycosylated forms of the ricin A chain were observed ( Figure 6A, lanes 2 and 4) . Therefore, ricin A chain dislocation probably occurs using a distinct mechanism compared to ERAD substrates.
To further explore the involvement of dislocation-associated cellular proteins in the transport of ricin toxin across the ER membrane, we investigated the role of SEL1L and Derlin-1 in the dislocation of RTA E177D and RTA Δ polypeptides. SEL1L functions as part of the mammalian Hrd1 ligase complex and is proposed to be involved in the recognition of ER degradation substrates (36, 37) . Derlin-1 plays a role in the extraction of certain misfolded ER proteins and a dominant negative form, Derlin-1-gfp can impede substrate dislocation (38) (39) (40) . U373 RTA-E177D and U373 RTAΔ transduced with Derlin1-gfp and shRNA against SEL1L were untreated or treated with ZL 3 VS (2.5 µM, 10 hrs) and subjected to immunoblot analysis ( Figure 6B ). The expression of the constructs was confirmed using anti-SEL1L ( Figure 6B , lanes 13-24) and anti-GFP ( Figure 6B, lanes  25-36) immunoblots. Derlin1-gfp expression did not alter the levels of RTA polypeptides regardless of proteasome inhibition ( Figure  6B , lanes 1-2, 4-5, 7-8, and 10-11). These results are consistent with published findings implicating that ricin toxin transport across the ER membrane is Derlin-1 independent (15) . On the other hand, silencing of SEL1L resulted in a substantial increase of RTA polypeptides in both the presence and absence of proteasome inhibition ( Figure 6B, lanes 3,  6, 9, 12 ). Anti-GAPDH immunoblot indicates equal protein loading ( Figure 6B, lanes 37-48) . These results imply that ricin can utilize specific components of ER quality control machinery to be dislocated across the ER membrane.
We next examined whether deficiency in SEL1L levels affects ricin toxicity ( Figure  7 ). Ricin holotoxin was exogenously administered to HeLa cells stably expressing shRNA against SEL1L or a control shRNA ( Figure 7A ). A control cell line (C1), a cell line revealing no SEL1L knockdown (120% of control; S8) and a cell line showing 53% knockdown (S24) were utilized in subsequent cytotoxicity experiments ( Figure 7A ). After inclusion of ricin holotoxin, the incorporation of radiolabeled amino acids into nascent polypeptides was measured by scintillation counting. Protection from toxin challenge would be demonstrated if the IC 50 ratio of SEL1L knockdown cells to control cells is greater than 1. The ricin IC 50 for S8 cells was equivalent to the C1 cell line ( Figure 7B ). In contrast, a significant protection from ricin was observed in the SEL1L knockdown cell line S24, ranging from 1.6-1.4 fold during the time course of ricin challenge ( Figure 7C ).
Collectively, ricin requires SEL1L for the dislocation of its A chain from the ER to the cytosol and subsequently induce toxicity.
The ricin A chain is not dislocated as a canonical soluble misfolded ER protein.
We compared the degradation intermediates of RTA and the canonical soluble ER degradation substrate, α 1 -antitrypsin-Hong Kong null (α 1 -AT HKnull ) variant (41, 42) . The total cell lysates of U373, U373 RTA-E177D , and U373 RTAΔ cells, and U373 cells that stably express the α 1 -AT HKnull variant (U373 α1-AT-HKnull ) were untreated or treated with ZL 3 VS (2.5 µM, 10 hrs) and subjected to immunoblot analysis (Figure 8 ). PDI levels confirmed equal protein loading (Figure 8 , lanes 17-24). As expected, both glycosylated and deglycosylated RTA E177D and RTA Δ molecules accumulated upon inclusion of proteasome inhibitor (Figure 8, lanes 4 and 6) . In sharp contrast, only an increase in glycosylated α 1 -AT HKnull species was observed in ZL 3 VS-treated cells (Figure 8, lane 16) . These results indicate that even though both RTA and α 1 -AT HKnull polypeptides represent soluble substrates of dislocation, RTA extraction across the ER membrane probably occurs in a directed manner to increase the likelihood of gaining access to the cytosol.
DISCUSSION
Ricin toxin co-opts the trafficking machinery and ER quality control to gain access to the cytosol. The current study has established a human cell based assay to study ricin dislocation by generating for the first time human cells that stably express enzymatic RTA mutants in the ER (Figure 2 ). Using this human cell based system, we demonstrated that ricin A chains were rapidly extracted from the ER in a directed manner utilizing specific ER factors to enhance its dislocation efficiency. These ER factors include the ER membrane itself ( Figure 5 ) as well as SEL1L, a component associated with the degradation of ER proteins (Figures 6-7) . These data support a model that RTA is transported out of the ER by a novel strategy of co-opting specific ER proteins and the ER bilayer to gain access to the cytosol.
Ricin toxin has evolved to selectively utilize cellular proteins to promote its dislocation across the membrane bilayer. The toxin likely undergoes a conformational change induced by the interaction with ER chaperones such as calreticulin and PDI (12, 13) , thus allowing its engagement with specific factors of the dislocation apparatus, SEL1L (Figures 6-7 ) and probably Hrd1 (16) . Yet, this process seems to act independent of Derlin-1 (Figure 6 and (15)), which is unlike cholera toxin whose dependence on Derlin-1 for dislocation remains in question (43) . SEL1L is as an auxiliary protein for E3-ubiquitin ligase hHrd1 (37) and the dependency of RTA dislocation on SEL1L would typically suggest that RTA is ubiquitinylated prior to dislocation. Despite the low number of lysines within ricin as observed for other toxins (44), ubiquitin conjugation to ricin A chains would be selective for the purposes of dislocation (3, 45) . Therefore, ricin can utilize SEL1L for dislocation and yet a population of the A chains can escape degradation to block protein synthesis (Figure 1) .
Once targeted for extraction out of the ER, we propose that ricin A chains utilize the hydrophobic nature of the bilayer to catalyze its dislocation ( Figure 5 ). The recovery of membrane integrated glycosylated A chains suggests that RTA is inserted into the bilayer due to a conformational change induced by its engagement with ER factors. In fact, RTA molecules associated with ER microsomes upon an increase in temperature suggests that extrinsic factors can induce a partial conformational change in ricin A chains (46) . The ability of ricin to insert into the bilayer would afford ricin dislocation to be less dependent on cellular proteins. Yeast cell studies demonstrate that wild type RTA dislocation is independent of the p97/Npl4/Ufd1 complex (16) . Therefore, membrane integration of RTA may provide some of the driving force for extraction out of the ER. Alternatively, ricin A chains may be extracted from the ER as a protein/lipid micelle (47) . In either case, RTA has evolved a unique strategy to efficiently cross the ER bilayer.
Ricin A chain contains only two lysines as a possible strategy to limit ubiquitin-dependent degradation (45) . Despite the low lysine number and the use of the protective nature of Hsc70, a population of ricin A chain is degraded by the proteasome (Figures 2-4 and (26) ). However, there are distinct differences between ricin A chain and misfolded ER proteins that demonstrate ricin co-opts select components of ER quality control to gain access to the cytosol. A major difference is observed in the dislocation kinetics of ricin as evaluated by the stability of glycosylated proteins and the accumulation of deglycosylated intermediate. This is apparent when compared to the levels of the canonical soluble misfolded ERAD substrate α 1 -AT HKnull in proteasome inhibitor treated cells ( Figure  8 ). Another factor may be its ability to integrate into the bilayer. Membrane integration may allow limited exposure to the degradation machinery and permit RTA to escape destruction for a period of time to inhibit protein synthesis (Figure 1) . Thus, the ricin has evolved strategies inherent to its sequence and structure to bypass ERAD to reach the cytosol and inhibit protein synthesis.
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The respective polypeptides and molecular weight markers are indicated. *Indicates faster migratory species. Figure 5 . RTA dislocation utilizes membrane components. Microsomal preparation from subcellular homogenates of U373 RTAΔ and U373 RTA-E177D cells were treated with or without 4.5 M urea and centrifuged at 100,000g. Total cell lysates, 100,000g pellets, and the 100,000g supernatant were subjected to immunoblot analysis against RTA (lanes 1-10) and p97 (lanes [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The respective polypeptides and molecular weight markers are indicated. 
